KRISTINE MEADE: Open Payments
NPI 1942648217 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,196 in 77 payments from 15 companies in 2025. Trend: 2023 $2,078 · 2024 $1,446 · 2025 $2,196
Food & beverage: $2,162Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $735 |
| Regeneron Healthcare Solutions, Inc. | 13 | $355 |
| GlaxoSmithKline, LLC. | 15 | $207 |
| GENZYME CORPORATION | 7 | $171 |
| Pharming Healthcare, Inc. | 1 | $125 |
| Genentech USA, Inc. | 4 | $107 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $106 |
| CSL Behring | 4 | $95 |
| Amgen Inc. | 3 | $71 |
| Grifols USA, LLC | 2 | $47 |
Products named: TEZSPIRE, DUPIXENT, NUCALA, AIRSUPRA, Xolair, NEFFY, Hizentra, FASENRA.
Industry payments across TN — which companies pay providers there.
